These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 803540)

  • 1. Studies of the hyperviscosity syndrome. II. Macroglobulinemia.
    MacKenzie MR; Babcock J
    J Lab Clin Med; 1975 Feb; 85(2):227-34. PubMed ID: 803540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperviscosity syndrome in plasma cell dyscrasias.
    Mehta J; Singhal S
    Semin Thromb Hemost; 2003 Oct; 29(5):467-71. PubMed ID: 14631546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability of plasma viscosity in monoclonal IgM gammopathies.
    Visentin I; Mares M; Bertolo C; Terribile V; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(5):747-58. PubMed ID: 1709909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1157-60. PubMed ID: 18326744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous occurrence of IgM-lambda paraprotein with pyroprecipitation properties and cryoglobulin in the serum of a patient with Waldenström's macroglobulinemia.
    Tichý M; Hrncír Z; Mracek J
    Neoplasma; 1978; 25(6):741-4. PubMed ID: 109780
    [No Abstract]   [Full Text] [Related]  

  • 6. Waldenström's macroglobulinemia: hyperviscosity syndrome and cryoglobulinemia.
    Stone MJ
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):97-9. PubMed ID: 19362986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood viscosity in Waldenström macroglobulinemia.
    MacKenzie MR; Lee TK
    Blood; 1977 Apr; 49(4):507-10. PubMed ID: 402961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombocytopenia in Waldenstrom's disease with specific antithrombocytic properties of the IgM paraprotein].
    Flury W; Riesen W; Morell A; Keller H
    Schweiz Med Wochenschr; 1975 Sep; 105(39):1241-5. PubMed ID: 809839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ophthalmologic techniques to assess the severity of hyperviscosity syndrome and the effect of plasmapheresis in patients with Waldenström's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):100-3. PubMed ID: 19362987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
    Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
    Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal IgM rheumatoid factor in a patient with rheumatoid arthritis and hyperviscosity syndrome.
    Rietveld AP; van Paassen HC
    Neth J Med; 1983; 26(6):157-9. PubMed ID: 6412149
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia.
    Abeykoon JP; Zanwar S; Ansell SM; Winters J; Gertz MA; King RL; Murray D; Habermann T; Dingli D; Muchtar E; Go RS; Leung N; Inwards DJ; Buadi FK; Dispenzieri A; Lacy MQ; Lin Y; Gonsalves WI; Kourelis T; Witzig TE; Thompson C; Vincent Rajkumar S; Kyle RA; Kumar S; Kapoor P
    Am J Hematol; 2018 Nov; 93(11):1384-1393. PubMed ID: 30121949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An autopsy case of Waldenström's macroglobulinemia with pyroglobulin, cryoglobulin and hyperviscosity syndrome (author's transl)].
    Deura K; Ishii Z; Shimoyama M; Minato K
    Rinsho Ketsueki; 1980 Feb; 21(2):240-50. PubMed ID: 6774129
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasmapheresis and cold sensitivity of immunoglobulin molecules. II. A study of macroglobulinemia polyclonalis spuria and immune complex disease.
    Waldenström JG
    Acta Med Scand; 1984; 216(5):467-74. PubMed ID: 6240922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Macroglobulinemia Waldenstrom with hyperviscosity syndrome].
    Bauer KH
    Med Welt; 1975 Feb; 26(8):341-8. PubMed ID: 803607
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperviscosity syndrome in paraproteinemia. Managed by plasma exchange; monitored by serum tests.
    Beck JR; Quinn BM; Meier FA; Rawnsley HM
    Transfusion; 1982; 22(1):51-3. PubMed ID: 6801828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of serum free light chains in a case of Waldenstrom's macroglobulinaemia that produces a type I cryoglobulinaemia.
    Pattenden RJ; Davidson KL; Wenham PR
    Ann Clin Biochem; 2009 Nov; 46(Pt 6):531-2. PubMed ID: 19822697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenström macroglobulinaemia.
    Gustine JN; Meid K; Dubeau T; Hunter ZR; Xu L; Yang G; Ghobrial IM; Treon SP; Castillo JJ
    Br J Haematol; 2017 Jun; 177(5):717-725. PubMed ID: 28485115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperviscosity-related retinopathy in waldenstrom macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Branagan A; Hunter Z; Treon SP
    Arch Ophthalmol; 2006 Nov; 124(11):1601-6. PubMed ID: 17102008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
    Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
    J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.